Merck
MRK
$0.32 (0.30%)
1D
1W
3M
1Y
5Y
ALL
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Reuters • 2 hours ago • MRK
Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 blnGlobeNewsWire • 4 hours ago • MRK
Modifi Biosciences Acquired by MerckZacks Investment Research • 1 day ago • MRK
Merck (MRK) Advances While Market Declines: Some Information for InvestorsSeeking Alpha • 2 days ago • MRK
3 Attractive Biotechs With Recent PositivesZacks Investment Research • 2 days ago • MRK
Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold?Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.